Big Pharma’s $300 Billion Patent Problem Fuels Biotech Deals

Published on July 18, 2026

Big Pharma has a $300 billion problem, and biotech developers with promising drugs are becoming the fix. Major drugmakers are spending at a pace not seen since 2019 to replace medicines that will soon lose patent protection.